Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null

June Liu1, Douglas P Thewke, Yan Ru Su

  • 1Department of Biochemistry and Molecular Biology, East Tennessee State University, Johnson City, TN 37614, USA.

Abstract

Insights

Macrophage apoptosis normally suppresses atherosclerosis. Bax deficiency in macrophages reduced apoptosis, significantly increasing atherosclerotic lesion size in mice, supporting this protective role.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Atherosclerosis Research

Background:

  • Macrophages are the predominant apoptotic cells in atherosclerotic lesions.
  • The role of macrophage apoptosis in atherosclerosis pathogenesis is not fully understood.
  • Bax, a proapoptotic protein, is elevated in human atherosclerotic plaques and activated in macrophages.

Purpose of the Study:

  • To investigate the impact of Bax deficiency in bone marrow-derived leukocytes on atherosclerosis development.
  • To determine if reduced macrophage apoptosis influences atherosclerotic lesion progression in low-density lipoprotein receptor-null (LDLR-/-) mice.

Main Methods:

  • Bone marrow from wild-type (WT) or Bax-null (Bax-/-) mice was used to reconstitute lethally irradiated LDLR-/- mice.
  • Mice were fed a Western diet for 10 weeks to induce atherosclerosis.
  • Plasma cholesterol, aortic lesion area, and macrophage apoptosis (TUNEL staining) were quantified.

Main Results:

  • No significant difference in plasma cholesterol levels between WT and Bax-/- groups.
  • Bax-/- mice exhibited a 49.2% increase in mean aortic lesion area compared to WT controls.
  • Macrophage apoptosis was reduced by 53% in the Bax-/- group.

Conclusions:

  • Reduced apoptotic activity in macrophages accelerates atherosclerosis development in LDLR-/- mice.
  • These findings support the hypothesis that macrophage apoptosis plays a suppressive role in atherosclerosis progression.